Foetal Anti-Convulsant Syndrome New Zealand
  • Home
  • About Our Trust Board What is FACS? FACS NZ Youth Ambassadors How to get a diagnosis Our strategic documents FACS OIA Requests Archives Petitions and Submissions
  • Resources
  • Support ACC FACS Videos
  • Funded Support Services
  • News
  • Contact
  • Mailing list
  • Donate Here
Foetal Anti-Convulsant Syndrome New Zealand
  • Home/
  • About/
    • About
    • Our Trust Board
    • What is FACS?
    • FACS NZ Youth Ambassadors
    • How to get a diagnosis
    • Our strategic documents
    • FACS OIA Requests
    • Archives
    • Petitions and Submissions
  • Resources/
  • Support/
    • Support
    • ACC FACS Videos
  • Funded Support Services/
  • News/
  • Contact/
  • Mailing list/
  • Donate Here/
Screenshot 2024-02-12 at 12.43.10 PM.png
Foetal Anti-Convulsant Syndrome New Zealand

News

Foetal Anti-Convulsant Syndrome New Zealand
  • Home/
  • About/
    • About
    • Our Trust Board
    • What is FACS?
    • FACS NZ Youth Ambassadors
    • How to get a diagnosis
    • Our strategic documents
    • FACS OIA Requests
    • Archives
    • Petitions and Submissions
  • Resources/
  • Support/
    • Support
    • ACC FACS Videos
  • Funded Support Services/
  • News/
  • Contact/
  • Mailing list/
  • Donate Here/

FACS News

Ansm Report: Antiepileptic drugs during pregnancy. Current state of knowledge on the risk of malformations and neurodevelopmental disorders - November 2023

Ansm Patient information: Antiepileptics and pregnancy plans

The lived experience of young adults with Fetal Valproate Spectrum Disorder, and the perspective of their parents: A qualitative study

The previously documented symptoms associated with FVSD have a substantial and lifelong impact on the daily lives of people with FVSD and their families. Families desire further research regarding the condition along with improved support and health services to better service this population.

“I think we're just glad that someone’s interested, because we had a long time before anyone took any note”. Mum 013

https://www.sciencedirect.com/science/article/pii/S1525505024000611

Restorative response to harm from Foetal Anticonvulsant Syndrome (FACS)

FACSNZ would like to thank the FACS community who were able to take the time to fill in the survey about those harmed by FACS.  We are pleased to announce that a report titled “A restorative response to harm from Foetal Anticonvulsant Syndrome (FACS). Findings from a survey of affected consumers” has been authored.  A copy of the report can be found here.

“This paper provides an overview of Foetal anticonvulsant syndrome (FACS) in Aotearoa New Zealand (Aotearoa NZ).  It explores who is at risk of harm from FACS and how consumers and whānau are affected.  Findings from a survey of FACSNZ community members are shared to illustrate their hopes and wishes for a restorative response.  The paper concludes by highlighting equity concerns and suggesting next steps.”

The National Collaborative for Restorative Initiatives in Health provided some recommendations which included “FACSNZ could approach Manatū Hauora to request a systemic response, noting that any response would need cross government.”  Prudence Walker, Disability Rights Commissioner, Human Rights Commission has written to Dr Sarfati to request a meeting to “…discuss possibilities for a restorative process for people affected by Foetal Anti-Convulsant Syndrome. “

 Without the valuable contribution of our FACSNZ community we would never have been able to produce some a valuable report.

“Most respondents (81.9%) indicated that they were experiencing the impacts of the harm severely (everyday), or moderately (most of the time).” Whilst this is probably not surprising to hear about our community, it is saddening to read. Hopefully officials reading this report will understand how life impacting this truly is.  Kia kaha

FACSNZ - If it is not safe, it is not care report

FACSNZ has complied a report to share their knowledge, and to provide recommendations to key government agencies following their attendance at the Fifth Global Ministerial Summit on Patient Safety

A copy of their report can be found here

International Research Opportunity

Researchers at the University of Manchester are recruiting mothers of children and young people with Fetal Valproate Spectrum Disorder/Fetal Valproate Syndrome for an online study investigating the health and neurodevelopment of individuals with FVSD/FVS as they grow older. The questionnaire will take no more than 30 minutes to complete and is open to mothers of children or young people aged 7 years and older with a diagnosis of FVSD/FVS. All participants must be fluent in English. Click on the link or scan the QR code on the image below for more information. Feel free to contact the researchers using the email addresses below if you have any questions about the study. https://tinyurl.com/2mrmmxuv

ICD-11 Update

We are pleased to announce that Fetal Valproate Spectrum Disorder is now officially part of the ICD-11 (latest version) - World Health Organisation.

We were part of the team that was successful in ensuring this happened.

It is not a diagnostic tool. It catalogues known human diseases, medical conditions, and mental health disorders and is used for insurance coding purposes, for statistical tracking of illnesses, and as a global health categorisation tool that can be used across countries.

It is incredibly important that FVSD is coded, as approximately 70% of health funding internationally is based on the ICD.

https://icd.who.int/browse11/l-m/en...

LOPE Petition

It is with great sadness that we have to announce that our petition to increase the Loss of Potential Earnings (LOPE) from 80% minimum wage to 100% median wage was declined in November last year.

In August we were advised that our petition was being removed from the Education and Workforce Committee and being given to the ACC Minister (Hon. Carmel Sepuloni). We requested a meeting with the Minister, to address some of the matters that we would have raised during an oral submission to the Education and Workforce Committee, but no meeting was forthcoming.

Instead, in November, we received notification that our petition, along with four other petitions (some of which had nothing to do with LOPE) had been declined.

What saddens us the most out of all of this is that you, our FACS whānau, who this affects, did not get your opportunity to get your voice heard.

In the meantime, when the minimum pay increase occurs on 1 April 2022, you, our affected people on LOPE, will not get an increase until 1 July 2022, as per the ACC legislation. This means you will be getting less than 80% minimum wage for 3 months, and miss out on receiving almost $500. How is this a fair or just system?

https://www.parliament.nz/.../69602f0b745ba33f37a1a3692c6...

New Foil on Epilim medication

Check out the old versus new foil that has the pregnancy pictogram on it. We have been advised from Medsafe that they believe this is the first ever medicine in New Zealand to get a pregnancy pictogram warning on the foil.

After FACSNZ was originally told no that it wasn't possible, we made it possible!

IMG_2971.jpg

Foetal Anti-Convulsant Syndrome New Zealand (FACSNZ) is excited to announce that we have partnered with Plunket

… to develop a training module for Plunket nurses. This module will help with assessing babies who may have been harmed by the use of antiepileptic medicines during pregnancy and identify at risk mothers. Plunket nurses will then be able to provide the correct support for the whanau and refer them to the appropriate support agencies.

Epilim: Hundreds of babies exposed to medicine known to cause birth defects 10th August 2019

https://www.stuff.co.nz/national/health/114461535/epilepsy-sufferer-warns-against-getting-pregnant-while-taking-epilim

Anti-epileptic drug sodium valproate faces restrictions after 26 babies born with serious disorder - New Zealand Herald 10th March 2019

https://www.nzherald.co.nz/spotlight/news/article.cfm?c_id=1504095&objectid=12211242

Tighter controls on epilepsy drug 'don't go far enough' to prevent harm to unborn babies - Stuff New Zealand 5th March 2019

https://www.stuff.co.nz/national/health/111028978/tighter-controls-on-epilepsy-drug-dont-go-far-enough-to-prevent-harm-to-unborn-babies-say-campaigners

Risks of anti-epileptic drugs during pregnancy- Radio New Zealand 25 January 2019 

https://www.radionz.co.nz/national/programmes/ninetonoon/audio/2018679693/risks-of-anti-epileptic-drugs-during-pregnancy

Understanding the experience of parents concerned about foetal valproate syndrome in their child

If you a mother who use(d) sodium valproate during pregnancy, and would like to take part in some research "Understanding the experience of parents concerned about fetal valproate syndrome in their child" please contact amanda.wood@mcri.edu.au. This research is for NZ and Australia.

https://www.facebook.com/facsnz/photos/a.916309485060876/2435044359854040/?type=3&theater

Health Select Committee

The Health Select Committee met again to hear the submissions from Ministry of Health/Medsafe and ACC. Here is a link to the live stream that was recorded on the day via Facebook https://www.facebook.com/facsnz/videos/318869522230995/ . Denise’s right of response can be viewed on YouTube https://www.youtube.com/watch?v=V9RgoyBSnvA

Denise Astill’s first presentation to the Health Select Committee was on Wednesday 26th of September 2018. To see her rehearsal please go to https://www.youtube.com/watch?v=4-w99lxH8zw

To read all of the submissions please go to https://www.parliament.nz/en/pb/sc/scl/health/tab/submissionsandadvice?criteria.Keyword=astill&criteria.Timeframe=&criteria.DateFrom=&criteria.DateTo=

Calls for public inquiry into anti-epileptic medicine use during pregnancy

https://www.stuff.co.nz/dominion-post/107898731/Calls-for-public-inquiry-into-anti-epileptic-medicine-use-during-pregnancy

Antiepileptic drugs in pregnancy: Why patients need to be warned (NZ Doctor Article), 1st December 2017

https://www.facebook.com/facsnz/photos/a.959590347399456/1930458200312661/?type=3&theater

 Launch of the ACC FACS Prevention toolkit

On the 23rd November 2017 the ACC FACS Prevention toolkit was launched. Watch the video of FACS NZ's Executive Officer Denise Astill address the audience via the link https://youtu.be/vdeFBaWfqZ4- 10th

FAS Prevention_20171123-34.jpg
23843317_1893241070701041_6897974390046139335_n.jpg
23926323_1899933013365180_6415931461775688042_o.jpg

Sodium Valproate in the news

http://www.radionz.co.nz/news/world/329200/research-confirms-epilepsy-drug-birth-defects

http://www.bbc.com/news/world-europe-39657139

FACS NZ - Making Change Happen!

FACS NZ are so pleased to announce that all of the hard work that we have pushed for in regards to Sanofi putting warnings on the NZ (and Australia) Epilim boxes has come into fruition. Today one of our mum's who has a child affected picked up her medication and it was on there.

Such a win!

**PLEASE DO NOT STOP TAKING YOUR MEDICATION WITHOUT SPEAKING TO YOUR HEALTHCARE PROFESSIONAL**

Education sessions tour completed. 

Thank you to those who attended the education sessions throughout the North and South Islands. They have been hugely successful and as a direct result from this there have already been further discussions with key parties. If you are wanting to have an education session in your area please contact denise@facsnz.com.

Anti-convulsant syndrome awareness

https://www.odt.co.nz/regions/north-otago/anti-convulsant-syndrome-awareness

Project Team formed for FACS Prevention

http://www.scoop.co.nz/stories/GE1605/S00135/project-team-formed-for-facs-prevention.htm

Toolkit on the risks of valproate medicines in female patients (Article from the UK)

https://www.gov.uk/government/publications/toolkit-on-the-risks-of-valproate-medicines-in-female-patients?utm_source=utm_source%3Dtwitter&utm_medium=utm_medium%3Demail&utm_campaign=Valproate

Campaigner hails new warnings on anti-epilepsy medication

https://www.tvnz.co.nz/one-news/new-zealand/campaigner-hails-new-warnings-on-anti-epilepsy-medication

Mum unaware her epilepsy drugs could harm her twins

https://www.tvnz.co.nz/one-news/new-zealand/mum-unaware-her-epilepsy-drugs-could-harm-twins

Use of Sodium Valproate (Epilim) in pregnancy

http://www.medsafe.govt.nz/safety/EWS/2015/sodiumvalproate.asp

Highlighting foetal syndrome

http://www.odt.co.nz/news/dunedin/350907/highlighting-foetal-syndrome

Drug Nightmare for Mums

http://www.stuff.co.nz/national/health/10576738/Drug-nightmare-for-mums

MHRA Article from the UK

https://www.gov.uk/government/news/stronger-advice-on-the-use-of-valproate-medicines-in-women

 

  • Home/
  • About/
    • About
    • Our Trust Board
    • What is FACS?
    • FACS NZ Youth Ambassadors
    • How to get a diagnosis
    • Our strategic documents
    • FACS OIA Requests
    • Archives
    • Petitions and Submissions
  • Resources/
  • Support/
    • Support
    • ACC FACS Videos
  • Funded Support Services/
  • News/
  • Contact/
  • Mailing list/
  • Donate Here/

Foetal Anti-Convulsant Syndrome New Zealand

 

Contact Us

Denise Astill
Executive Officer
Foetal Anti-Convulsant Syndrome NZ


Email: denise@facsnz.com
Facebook: www.facebook.com/facsnz

PO Box 82-175
Highland Park
Auckland, 2143
New Zealand

Powered by Squarespace.